Purchases and Sales Made in Q4 2023 in Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY) during Q4 2023. The information is specifically focused on institutions that hold shares of Unicycive Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Ra Capital Management, L.P.
Boston, MA |
BUY
|
- |
3.47MNew |
$1.7M - $3.19M
|
3.47M
$2.81M
|
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
117K+ 222.78% |
$57.2K - $107K
|
169K
$137K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
35.4KNew |
$17.4K - $32.6K
|
35.4K
$28.7K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
34.1KNew |
$16.7K - $31.4K
|
34.1K
$27.6K
|
|
|
Feb 13, 2024
Q4 2023
|
Integrated Wealth Concepts LLC
|
BUY
|
- |
10KNew |
$4.9K - $9.2K
|
10K
$8.1K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.69K+ 120.31% |
$1.81K - $3.4K
|
6.76K
$5.47K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
154+ 394.87% |
$75.5 - $142
|
193
$156
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
111+ 0.12% |
$54.4 - $102
|
93.3K
$75.6K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-542- 75.49% |
$266 - $499
|
176
$143
|
|
|
Feb 14, 2024
Q4 2023
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-32.4K- 0.93% |
$15.9K - $29.8K
|
3.44M
$2.78M
|
|
|
Feb 14, 2024
Q4 2023
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-1.3M- 37.95% |
$635K - $1.19M
|
2.12M
$1.72M
|